je.st
news
Tag: announces thirdquarter
Windstream Announces Third-Quarter Earnings Call
2014-10-04 10:58:13| Grocery - Topix.net
Windstream will hold a conference call at 7:30 a.m. CST on Nov. 6 to review the company's third-quarter earnings results. Interested parties can access the call by dialing 1-877-374-3977, conference ID 15971005, ten minutes prior to the start time.
Tags: call
earnings
announces
announces thirdquarter
Merck Announces Third-Quarter 2014 Dividend
2014-05-27 18:21:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.44 per share of the companys common stock for the third quarter of 2014. Payment will be made on July 8, 2014, to stockholders of record at the close of business on June 16, 2014. About Merck Language: English Contact: MerckMedia:Lainie Keller, 908-423-4187orInvestors:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: announces
dividend
merck
announces thirdquarter
La-Z-Boy Announces Fiscal 2014 Third-Quarter Conference Call
2014-02-06 22:43:37| Furniture - Topix.net
The call will also be webcast live and archived on the Internet, and will be available at http://investors.la-z-boy.com/phoenix.zhtml?c=92596&p=irol-calendar .
Tags: call
conference
fiscal
announces
Merck Announces Third-Quarter 2013 Financial Results
2013-10-28 12:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. 2013 Third-Quarter Non-GAAP EPS of $0.92, Excluding Certain Items; GAAP EPS of $0.38 Worldwide Sales were $11.0 Billion, a Decrease of 4 Percent Reflecting the Unfavorable Impact of Patent Expiries and a 2 Percent Negative Impact from Foreign Exchange Strong Growth in Vaccines and Immunology as well as ISENTRESS Breakthrough Therapy Designation Granted for MK-5172/MK-8742, in Development for the Treatment of Chronic Hepatitis C Virus Infection; V503, Mercks Investigational 9-valent HPV Vaccine has Completed Pivotal Phase III Study, on Track for 2013 Submission Narrows Full-Year Non-GAAP EPS Target to $3.48 to $3.52; GAAP EPS Target to $1.61 to $1.79 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2013. $ in millions, except EPS amounts ThirdQuarter2013 ThirdQuarter2012 Language: English Contact: MerckMedia Contacts:Kelley Dougherty, 908-423-4291Steven Cragle, 908-423-3461orInvestor Contacts:Carol Ferguson, 908-423-4465Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck
Merck Announces Third-Quarter 2013 Dividend
2013-05-28 21:31:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.43 per share on the companys common stock for the third quarter of 2013. Payment will be made on July 8, 2013, to stockholders of record at the close of business on June 17, 2013. About Merck Language: English Contact HTML: MerckMedia Contact:Kelley P. Dougherty, 908-423-4465orInvestor Contact:Carol Ferguson, 908-423-4291 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: announces
dividend
merck
announces thirdquarter
Sites : [1] [2]